NASDAQ:KMDA

Kamada Stock News

Healthcare > Drug Manufacturers - Specialty & Generic

Buy KMDA

*Your capital is at risk

$7.14

+0.0400 (+0.563%)

At Close: Jul 31, 2026

KMDA vs. CSLLY: Which Stock Should Value Investors Buy Now?

12:46pm, Wednesday, 28'th May 2025

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Kamada (KMDA) or CSL Limited Sponsored ADR (CSLLY). But which of these two stocks presents in

Wall Street Analysts Believe Kamada (KMDA) Could Rally 106.56%: Here's is How to Trade

11:01am, Friday, 16'th May 2025

The mean of analysts' price targets for Kamada (KMDA) points to a 106.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts

Kamada Ltd. (KMDA) Q1 2025 Earnings Call Transcript

01:48pm, Wednesday, 14'th May 2025

Start Time: 08:30 January 1, 0000 8:53 AM ET Kamada Ltd. (NASDAQ:KMDA ) Q1 2025 Earnings Conference Call May 14, 2025, 08:30 AM ET Company Participants Amir London - CEO Chaime Orlev - CFO Brian Ritch

Compared to Estimates, Kamada (KMDA) Q1 Earnings: A Look at Key Metrics

10:30am, Wednesday, 14'th May 2025

While the top- and bottom-line numbers for Kamada (KMDA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to

Kamada (KMDA) Q1 Earnings Match Estimates

09:10am, Wednesday, 14'th May 2025

Kamada (KMDA) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago.

Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability

07:00am, Wednesday, 14'th May 2025

REHOVOT, Israel and HOBOKEN, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ra

Kamada (KMDA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

10:20am, Friday, 09'th May 2025

Besides Wall Street's top -and-bottom-line estimates for Kamada (KMDA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua

Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas

07:00am, Wednesday, 19'th Mar 2025

REHOVOT, Israel and HOBOKEN, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for

Kamada Ltd. (KMDA) Q4 2024 Earnings Call Transcript

11:06am, Wednesday, 05'th Mar 2025

Kamada Ltd. (NASDAQ:KMDA ) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Company Participants Brian Ritchie – LifeSci Advisors Amir London – Chief Executive Officer Chaime Orlev – Ch

Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth

07:05am, Wednesday, 05'th Mar 2025

REHOVOT, Israel, and HOBOKEN, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by